A single-arm study of the efficacy of pemafibrate in patients with NAFLD (non-alcoholic fatty liver disease) complicated by dyslipidemia
Not Applicable
- Conditions
- AFLD (non-alcoholic fatty liver disease) complicated by dyslipidemia
- Registration Number
- JPRN-UMIN000049937
- Lead Sponsor
- ippon Medical School, gastroenterology, Hiroki Ono
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 91
Inclusion Criteria
Not provided
Exclusion Criteria
The main exclusion criteria were as follows: (1) age <20\x{2009}years; (2) new administration of vitamin E, pioglitazone, SGLT2-Is, and GLP-1 RA known to be potentially effective for NAFLD and other antilipidemic agents within 12\x{2009}weeks prior to pemafibrate treatment; (3) decompensated cirrhosis; and (4) pregnancy or lactation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method